Company Analysis Stryker
1. Summary
Advantages
- The stock's return over the last year (26.42%) is higher than the sector average (-0.7555%).
- Current debt level 32.56% is below 100% and has decreased over 5 years from 33.91%.
- The company's current efficiency (ROE=17.02%) is higher than the sector average (ROE=-80.86%)
Disadvantages
- Price (365.66 $) is higher than fair price (103.37 $)
- Dividends (0.8958%) are below the sector average (1.31%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
18 november 17:15 Medical-device makers gain amid return to normalcy
2.3. Market efficiency
| Stryker | Healthcare | Index | |
|---|---|---|---|
| 7 days | 2.8% | 2.4% | 0.6% |
| 90 days | 11.8% | -4.9% | 1.5% |
| 1 year | 26.4% | -0.8% | 22.4% |
SYK vs Sector: Stryker has outperformed the "Healthcare" sector by 27.17% over the past year.
SYK vs Market: Stryker has outperformed the market by 3.99% over the past year.
Stable price: SYK is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: SYK with weekly volatility of 0.508% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (365.66 $) is higher than the fair price (103.37 $).
Price is higher than fair: The current price (365.66 $) is 71.7% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (36.07) is lower than that of the sector as a whole (57.87).
P/E vs Market: The company's P/E (36.07) is lower than that of the market as a whole (47.68).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (6.14) is lower than that of the sector as a whole (9.39).
P/BV vs Market: The company's P/BV (6.14) is lower than that of the market as a whole (22.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (5.57) is higher than that of the sector as a whole (4.07).
P/S vs Market: The company's P/S indicator (5.57) is lower than that of the market as a whole (15.21).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (25.08) is higher than that of the sector as a whole (17.62).
EV/Ebitda vs Market: The company's EV/Ebitda (25.08) is higher than that of the market as a whole (24.31).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 19.56% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (19.56%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-66.62%).
5.4. ROE
ROE vs Sector: The company's ROE (17.02%) is higher than that of the sector as a whole (-80.86%).
ROE vs Market: The company's ROE (17.02%) is lower than that of the market as a whole (18.08%).
5.5. ROA
ROA vs Sector: The company's ROA (7.93%) is higher than that of the sector as a whole (6.71%).
ROA vs Market: The company's ROA (7.93%) is higher than that of the market as a whole (6.49%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (7.23%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (7.23%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.8958% is below the average for the sector '1.31%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.8958% has been steadily paid over the past 7 years, DSI=1.
Dividend growth: Company's dividend yield 0.8958% has been growing over the last 5 years. Growth over 14 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (35.99%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
